Jun 14, 2024
38:35
For every 35 shares held, investors received 38.
The split itself did not change the total investment value.
Ceryvyn Therapeutics Limited (ASX:CYV) operates in the Biotechnology industry.
Ceryvyn Therapeutics Limited company overviewCeryvyn Therapeutics Limited's most recent stock split was on June 14, 2024. It was a 38-for-35 forward split, so shareholders received 38 shares for every 35 they held.
Ceryvyn Therapeutics Limited has split its stock once. This history records one forward split, on June 14, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Ceryvyn Therapeutics Limited's 38-for-35 split on June 14, 2024, every 35 shares became 38 shares.
Ceryvyn Therapeutics Limited has not announced a new split in our records. Its most recent split was on June 14, 2024, 2 years ago. Companies announce splits in advance, and any new ASX:CYV split will appear on this page.
Already premium?